-An overview of the study design. We recruited a cohort of 30 elderly patients (average age = 77.9 years) undergoing major surgery (colorectal elective surgery (n = 11), elective hip replacement surgery (n = 10), and hip fracture surgery (n = 9)). From each individual, detailed blood measures were collected and DNA methylation was profiled using the Illumina HumanMethylation450 array in DNA samples isolated from peripheral blood mononuclear cells (PBMCs) collected at three time-points: i) immediately before surgery (baseline), ii) in the morning of post-operative day 1 (POD1) and iii) on postoperative day 4 to 7 (POD4/7) before discharge from hospital. Figure S2 -Manhattan plot for acute DNA methylation changes associated with major surgery. Within each individual, DNA methylation was compared between BL and POD1. Red line = experiment-wide significance threshold (P < 2.0E-07). Blue line = discovery significance threshold (P < 5.0E-05) used for gene ontology analysis.
-Surgery-induced change in an inflammation-related polyepigenetic score reflect perioperative levels of CRP and IL-6. A) Within each individual, the average polyepigenetic score was significantly increased at POD1 (P = 2.7E-04) and at POD4/7 (P = 3.3E-04), indicating upregulation of the immune system following surgery (Barker et al., 2018) . Scatter plots show the correlation between the inflammationrelated polyepigenetic score and B) serum CRP and C) IL-6. Figure S4 -Surgery-induced change in an epigenetic biomarker of age. The average GrimAge 22 estimate was increased at POD1 compared to BL (mean change in GrimAge = 1.64 years, P = 2.57E-04). Error bar show the 95% confidence interval. Figure S5 -Surgery is associated with acute changes in the cellular composition of blood. Significant acute changes were observed in blood cellular composition following surgery including an increase in white blood cell count (baseline: mean white blood cell count = 9.73 *1.000/µl; POD1: mean white blood cell count = 11.35 *1.000/µl, P = 4.08E-02), neutrophil count (baseline: mean neutrophil count = 7.57 *1.000/µl; POD1: mean neutrophil count = 9.33 *1.000/µl, P = 3.00E-02), and monocyte count (baseline: mean monocyte count = 0.68 *1.000/µl; POD1: mean monocyte count = 0.85 *1.000/µl, P = 5.64E-03), and decreases in red blood cell count (baseline: mean red blood cell count = 4.04 *10E6/µl; POD1: mean red blood cell count = 3.38 *10E6/µl, P = 3.24E-09), platelets (baseline: mean platelets = 247.5 *1.000/µl; POD1: mean platelets = 212.5 *1.000/µl, P = 8.66E-07), lymphocyte count (baseline: mean lymphocyte count = 1.28 *1.000/µl; POD1: mean lymphocyte count = 1.11 *1.000/µl, P = 2.34E-02), eosinophil count (baseline: mean eosinophil count = 0.15 *1.000/µl; POD1: mean eosinophil count = 0.04 *1.000/µl, P = 4.03E-03) and basophil count (baseline: mean basophil count = 0.05 *1.000/µl. Figure S6 -Surgery is associated with acute changes in multiple blood plasma measures. Significant acute changes were observed in plasma-based blood measures including an increase in bilirubin (baseline: mean bilirubin = 8.2 µmol/l; POD1: mean bilirubin = 13.3 µmol/l, P = 4.19E-03), and decreases in alkaline phosphatase (baseline: mean alkaline phosphatase = 82.8 iu/l; POD1: mean alkaline phosphatase = 66.9 iu/l, P = 1.15E-05), albumin (baseline: mean albumin = 44.2 g/l; POD1: mean albumin = 35.6 g/l, P = 1.19E-10), and sodium (baseline: mean sodium = 137.9 mEq/l; POD1: mean sodium = 135.7 mEq/l, P = 2.41E-04), haemoglobin (baseline: mean haemoglobin = 123.4 g/l; POD1: mean haemoglobin = 102.7 g/l, P = 5.33E-09) and haematocrit (baseline: mean haematocrit = 36.9 %; POD1: mean haematocrit = 30.6 %, P = 6.16E-09). Error bars show the 95% confidence interval. BL: baseline, POD1: postoperative day1, POD4/7: postoperative day 4 to postoperative day 7. Figure S7 -Blood cell proportion estimates derived from DNA methylation data are correlated with empirical cell-type measures. Shown is the correlation between empirically-measured ratios between monocytes and lymphocytes and those derived from DNA methylation data in peripheral mononuclear cells (n = 86, r = 0.713, P = 8.53E-15). Figure S8 -There was a strong correlation for effect sizes (r = 0.955, P = 2.20E-47) between models (corrected and uncorrected for derived cell proportions) for DMPs identified in our uncorrected model. Figure S9 -There was a strong correlation for P values (r = 0.621, P = 6.45E-11) between models (corrected and uncorrected for derived cell proportions) for DMPs identified in our model uncorrected for blood cell-type proportions.
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Supplementary Figure S10 -Manhattan plot for acute DNA methylation changes associated with major surgery in a model correcting for blood cell-type proportions.
Within each individual, DNA methylation was compared between BL and POD1. Red line = experiment-wide significance threshold (P < 2.0E-07). Blue line = discovery significance threshold (P < 5.0E-05) used for gene ontology analysis.
Supplementary Figure S11 -Manhattan plot for DNA methylation changes between BL and POD4/7 associated with major surgery in a model correcting for blood cell-type proportions. Red line = experiment-wide significance threshold (P < 2.0E-07). Blue line = discovery significance threshold (P < 5.0E-05) used for gene ontology analysis. Figure S16 -Surgery-type-specific DMPs (P < 2.0E-07) at POD1. Data for each of these eight DMPs is given in Supplementary Table 11.   cg02752174  cg21866054  cg18739142  cg27118526  cg12260798  cg08928145  cg01023798  cg04634483 DNA methylation difference (%) (POD1 − BL)
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